IRCT20150706023081N4Not yet recruitingPhase 3
Comparison of the effectiveness of combined treatment of topical l-carnitine 1% and clotrimazole 2% with clotrimazole 2% alone, in patients with scalp seborrheic dermatitis
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Enrollment
- 64
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- All
Inclusion Criteria
- •Having seborrheic dermatitis in the scalp area with clinical diagnosis
- •No treatment with topical or systemic corticosteroids for the previous four weeks
- •No treatment with methyldopa, chlorpromazine, local or systemic anti-acne drugs for one month before
- •Absence of systemic diseases such as Parkinson's, AIDS and mood disorders
Exclusion Criteria
- •Lack of consent to continue participating in the study
- •Breastfeeding
Investigators
Similar Trials
Recruiting
Phase 3
Investigating the effect of platelet-rich plasma in androgenetic alopeciaAndrogenetic alopecia.Androgenic alopeciaIRCT20221230056991N1Esfahan University of Medical Sciences60
Not yet recruiting
Phase 2
Effectiveness of Combined Treatment of Carboxytherapy, Platelet-Rich Plasma (PRP) and Local Finasteride with Platelet-Rich Plasma in the Treatment of Androgenic Hair LossAndrogenic hair loss.Cicatricial alopecia [scarring hair loss]IRCT20220919055994N1Kerman University of Medical Sciences20
Not yet recruiting
Phase 2
Comparison of outcomes of single drug therapy versus dual drug therapy in the treatment of hemodynamically significant PDACTRI/2024/05/066914Govind Choudhary
Completed
Not Applicable
Comparison of the therapeutic benefit to combination therapy of botulinum neurotoxin and cast as well as single dose of botulinum neurotoxin on the wrist spasticity in different time intervalsG81.1I63.9Spastic hemiplegiaCerebral infarction, unspecifiedDRKS00010413eurologisches Rehabilitationszentrum Leipzig60
Not yet recruiting
Phase 4
comparison of newer and higher dose antibiotics combination therapy with old and standard antibiotics combination therapy in critically ill patients who are carbapenem resistant enterobacteriaceae (CRE)CTRI/2022/09/045736Department of Anaesthesiology and Critical and Care Jawaharlal Nehru Medical College AMU Aligarh